Selecting a dosage form for delivery to the lungs

REC130 Download PDF Now!

Selecting and developing an appropriate dosage form for inhalation products can be challenging. The physicochemical properties of the API, the required dose, the target patient population, timeline and budget are all important considerations.

Other factors, such as biopharmaceutics, intellectual property, marketing and the competitive landscape, may also be relevant. Download Recipharm’s free inhalation whitepaper here for all you need to know when selecting an appropriate dosage form for drug delivery to the lungs.

 

Latest content from Recipharm AB

980x350

Content Provided by Recipharm AB

Developing a new high throughput screen method to improve excipient selection for solubilisation

Recipharm_Image

Content Provided by Recipharm AB

Take steps to stay in the serialization race

More content

Related resources

Supplier's Info Centre